1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Durvalumab with etoposide and platinum-based chemotherapy for untreated extensive-stage small-cell lung cancer [ID6404]

Awaiting development [GID-TA11515] Expected publication date: 09 January 2025

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Invitation to participate

  • Final scope PDF 197 KB 15 July 2024  
  • Final stakeholder list PDF 213 KB 15 July 2024  
  • NICE's response to comments on the draft scope and provisional stakeholder list PDF 234 KB 15 July 2024  
  • Equality impact assessment (scoping) PDF 126 KB 15 July 2024